Blood test predicts MS disability worsening up to two years in advance

Multiple sclerosis patients whose blood tests reveal elevated NfL, a biomarker of nerve damage, could see worsening disability one to two years later, according to a new study spearheaded by researchers at UC San Francisco.

Sales of emergency contraception estimated to rise after the New Year holiday

Sales of emergency contraception are estimated to rise by around 10% in the US in the week after the New Year holiday, suggesting that this

December 22, 2023

Roundups: 21 Recent Strategic Digital Health Partnerships

Advantus Health Partners forms a new 10-year, $2.9B strategic partnership with Medline to establish agility and scale, supply chain resiliency and enhanced clinical integration with

June 29, 2023

Jazz Pharmaceuticals bids for Chimerix in $935m deal – Pharmaceutical Technology

Dordaviprone is under review with the FDA for a rare and aggressive brain tumour. Credit: LumiNola via Getty Images. Jazz Pharmaceuticals has announced a definitive

March 5, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.